Cargando…
Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
Vaccination is a key component of public health policy with demonstrated cost-effective benefits in protecting both human and animal populations. Vaccines can be manufactured under multiple forms including, inactivated (killed), toxoid, live attenuated, Virus-like Particles, synthetic peptide, polys...
Autores principales: | Ghattas, Majed, Dwivedi, Garima, Lavertu, Marc, Alameh, Mohamad-Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708925/ https://www.ncbi.nlm.nih.gov/pubmed/34960236 http://dx.doi.org/10.3390/vaccines9121490 |
Ejemplares similares
-
Biomimetic Membranes as a Technology Platform: Challenges and Opportunities
por: Hélix-Nielsen, Claus
Publicado: (2018) -
Estrogens in schizophrenia: progress, current challenges and opportunities
por: Brand, Bodyl A., et al.
Publicado: (2021) -
Maternal vaccination—current status, challenges, and opportunities
por: Kurasawa, Kentaro
Publicado: (2022) -
Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery
por: Alameh, Mohamad, et al.
Publicado: (2012) -
Challenges and opportunities in current vaccine technology and administration: A comprehensive survey examining oral vaccine potential in the United States
por: Rupassara, S. Indu, et al.
Publicado: (2022)